Identification of an Orally Bioavailable, Brain-Penetrant Compound with Selectivity for the Cannabinoid Type 2 Receptor.

Ospanov M, Sulochana SP, Paris JJ, Rimoldi JM, Ashpole N, Walker L, Ross SA, Shilabin AG, Ibrahim MA

Open source

DOI: 10.3390/molecules27020509
Published: 2022 Jan 14
Container: Molecules (Basel, Switzerland)
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3390/molecules27020509,
  title = {Identification of an Orally Bioavailable, Brain-Penetrant Compound with Selectivity for the Cannabinoid Type 2 Receptor.},
  author = {Ospanov M and Sulochana SP and Paris JJ and Rimoldi JM and Ashpole N and Walker L and Ross SA and Shilabin AG and Ibrahim MA},
  year = {2022},
  journal = {Molecules (Basel, Switzerland)},
  doi = {10.3390/molecules27020509},
  url = {https://doi.org/10.3390/molecules27020509}
}

RIS

TY  - JOUR
TI  - Identification of an Orally Bioavailable, Brain-Penetrant Compound with Selectivity for the Cannabinoid Type 2 Receptor.
AU  - Ospanov M
AU  - Sulochana SP
AU  - Paris JJ
AU  - Rimoldi JM
AU  - Ashpole N
AU  - Walker L
AU  - Ross SA
AU  - Shilabin AG
AU  - Ibrahim MA
PY  - 2022
JO  - Molecules (Basel, Switzerland)
DO  - 10.3390/molecules27020509
UR  - https://doi.org/10.3390/molecules27020509
ER  -

APA

M, O., SP, S., JJ, P., JM, R., N, A., L, W., SA, R., AG, S., & MA, I. (2022). Identification of an Orally Bioavailable, Brain-Penetrant Compound with Selectivity for the Cannabinoid Type 2 Receptor.. Molecules (Basel, Switzerland). https://doi.org/10.3390/molecules27020509

Source records

pubmed · retrieved 2026-09-26T00:28:09.290Z
europe-pmc · retrieved 2026-09-26T00:28:09.302Z
doaj · retrieved 2026-09-26T00:28:09.323Z